Docusign is rated Buy with a $81 price target, offering 14% upside potential and market outperformance over the next 12 months. DOCU trades at a 25% discount to sector median P/E, despite exceptional ...
Docusign's growth has slowed post-pandemic, with revenue growth at 7.78% YoY in FY2025 and a slight dip in client count, raising concerns about future prospects. Despite operational strengths like a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback